Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026)
Gilead Sciences' (GILD) quarterly Exchange Rate Effect came in at -$11.0 million in Q1 2026, down 157.89% YoY from $19.0 million in Q1 2025, and down 320.0% on a QoQ basis from $5.0 million in Q4 2025.
Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Exchange Rate Effect data on file, last reported at -$11.0 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 157.89% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.0 million (up 2166.67% YoY) and the FY2025 annual result came in at $92.0 million, up 330.0% from the prior year.
- Exchange Rate Effect slipped to -$11.0 million in Q1 2026, from $5.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $75.0 million in Q4 2022 to a low of -$72.0 million in Q3 2022.
- A 5-year average of $2.1 million and a median of -$5.0 million in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 933.33% in 2022, down 340.0% in 2022.
- Tracing GILD's Exchange Rate Effect over 5 years: stood at $75.0 million in 2022, then sank by 50.67% to $37.0 million in 2023, then tumbled by 248.65% to -$55.0 million in 2024, then jumped by 109.09% to $5.0 million in 2025, then sank by 320.0% to -$11.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$11.0 million (Q1 2026), $5.0 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.59 Bn | 632.83 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 470.48 Bn | 463.91 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 375.12 Bn | 367.98 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 302.96 Bn | 295.27 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.26 Bn | 252.36 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 237.14 Bn | 223.15 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.99 Bn | 179.82 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 160.23 Bn | 148.53 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.11 Bn | 101.94 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.00 Mn |
| Jun 30, 2026 | -19.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 73.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -55.00 Mn |
| Dec 31, 2024 | -55.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -18.00 Mn |
| Mar 31, 2024 | -18.00 Mn |